FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks

A majority of the FDA panel said GSK's vaccine safety data was adequate, and the advisors were unanimous that the shot's efficacy was good.

from Health and Science https://ift.tt/YGgkDwu
https://ift.tt/kFVacxf
https://ift.tt/cDIymMi